Agency Forms Undergoing Paperwork Reduction Act Review, 12347-12348 [2024-03241]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 89, Number 33 (Friday, February 16, 2024)]
[Notices]
[Pages 12347-12348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03241]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-1186]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Information Collection for Tuberculosis 
Data from Referring Entities to CureTB'' to the Office of Management 
and Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on December 15, 2023 to obtain comments from 
the public and affected agencies. CDC did not receive comments related 
to the previous notice. This notice serves to allow an additional 30 
days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Information Collection for Tuberculosis Data from Referring

[[Page 12348]]

Entities to CureTB (OMB Control No. 0920-1186, Exp. 02/29/2024)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The CureTB program works to prevent the spread of tuberculosis (TB) 
among people who cross international borders. To reduce disease 
transmission and the emergence of drug-resistant TB, CureTB connects 
people with TB to healthcare services as they move between the United 
States and other countries. The program is a collaboration between 
CDC's Division of Global Migration Health (DGMH) and the County of San 
Diego's Tuberculosis Control Program. CureTB collaborates with health 
authorities throughout the United States and around the world to link 
people with TB to care at their destinations. Health departments, 
healthcare providers, and others seeking help in linking patients to 
ongoing TB care in other countries can refer patients to CureTB.
    Information will be collected from the referring entities, which 
are State and local health departments and Federal immigration and 
detention agencies. Whenever the referring entities provide clinical 
services to an individual with TB who has imminent plans to relocate, 
and an individual needs continuity of care in their new location, CDC 
CureTB is contacted to assist with coordinating that care. TB patients 
may also be a respondent if critical clinical or contact data is 
missing and requires follow-up by CureTB to complete a patient's 
referral information set. The request for CDC CureTB services comes 
from the referring entities and they supply the information at the time 
the patient is likely to leave their jurisdiction. The referring 
entities update information only if relevant information to the 
patient's care becomes available to them after their first 
communication with CDC CureTB. Therefore, information is already 
largely collected by CDC CureTB only at one point in time, with 
subsequent information only collected if departure is delayed or when 
initially pending information becomes available and this is beyond the 
control of CDC.
    Post relocation of the TB patient, data is also collected from the 
receiving physicians to determine patient outcomes. CDC CureTB contacts 
the physician an average of every two months during the standard six-
month TB treatment process. The data provides valuable information on 
globally mobile populations and allows CDC to assist in continuity of 
TB care and monitor the effectiveness of the program.
    The continuous expansion and use of the CureTB Program requires 
certain processes be evaluated. The Supplemental CureTB Program Partner 
Satisfaction Assessment Questionnaire will guide CureTB in making 
appropriate program improvements to best serve referring partners. The 
Questionnaires will not be used to collect demographic or clinical 
information, rather, they will ask the referring partners about their 
experience separately from the other forms already used for demographic 
and clinical information for each patient.
    As part of this revision request, CureTB is updating the number of 
respondents and total burden hours. There are no changes to the data 
collection instruments. CDC requests OMB approval for an estimated 
1,139 annual burden hours. There are no costs to respondents other than 
their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                       Average
                                                                        Number of       Number of     burden per
          Type of respondents                     Form name            respondents    responses per    response
                                                                                       respondent     (in hours)
----------------------------------------------------------------------------------------------------------------
U.S. Health Departments................  CureTB Transnational                   100               3        30/60
                                          Notification.
TB patients referred by U.S. health      CureTB Transnational                   200               1         5/60
 departments.                             Notification.
TB patients referred by ICE............  CureTB Transnational                   600               1        45/60
                                          Notification.
TB treating physicians in new country..  CureTB Telephone Script                900               3        10/60
                                          Clinician/foreign health
                                          authority Referral Follow-
                                          up.
U.S. Health Departments................  CureTB Contact/Source                   20               5        30/60
                                          Investigation (CI/SI)
                                          Notification.
U.S. Health Department (Local & State).  CureTB Partner Feedback                100               1        10/60
                                          (Satisfaction
                                          Assessment)--Questionnair
                                          e 1.
U.S. Health Department.................  CureTB Partner Feedback                 50               1         6/60
                                          (Satisfaction
                                          Assessment)--Questionnair
                                          e 2.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-03241 Filed 2-15-24; 8:45 am]
BILLING CODE 4163-18-P